Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|November 9, 2025
Investigating the anti-atherosclerotic mechanisms of Panax notoginseng saponins through integrated cell experiments, online preparative high-performance liquid chromatography, network pharmacology, molecular docking, and molecular dynamics simulationsWeiye Zhang, Yunxiang Zhou, Yi Cui, et al.Journal of Medicinal Chemistry|June 16, 2026
Discovery of Hirsutellones as Nucleolin-Targeting Natural Macrocycles for Triple-Negative Breast Cancer TreatmentLizhi Gong, Jin Yang, Jiacheng Guo, et al.Journal of Clinical Microbiology|August 19, 2016
Detection of Anti-Hepatitis B Virus Drug Resistance Mutations Based on Multicolor Melting Curve AnalysisYi Mou, Muhammad Ammar Athar, Yuzhen Wu, et al.BMC Microbiology|September 28, 2024
Novel genomic and phenotypic traits of polyhydroxyalkanoate-producing bacterium ZZQ-149, the type strain of Halomonas qinghailakensisZiqiang Zheng, Zuoqian Wang, Xuerui Zhang, et al.Food Chemistry|September 16, 2025
Separation, characterization, AI screening, and bioactivities of marine bioactive peptides: A reviewYi Cui, Xiaorui Li, Yiran Sun, et al.Cancer|December 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinomaLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.British Journal of Cancer|July 11, 2026
TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinomaXiaohe Su, Kaifeng Jin, Han Zeng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinomaZhaopei Liu, Lingkai Zhang, Kaifeng Jin, et al.Journal for Immunotherapy of Cancer|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinomaYawei Ding, Kaifeng Jin, Xiaohe Su, et al.Journal for Immunotherapy of Cancer|January 6, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionKaifeng Jin, Yawei Ding, Jingtong Xu, et al.Pageof 7